Scope of the Study
Plasmapheresis machines is a medical device designed to remove some plasma from the blood. It is used before the plasma exchange to swap a unhealthy plasma to healthy plasma or a plasma substitute. Plasmapheresis machine collects and separate the plasma from blood components for donation; they can also remove or exchange substances in therapeutic procedures and this is projected the growth of the plasmapheresis machine market in the forecast period.
The market study is being classified by Type (Multi-component collection System and Single-component collection System), by Application (Renal Disease, Hematology and Neurology) and major geographies with country level break-up.
Haemonetics Corporation (United States), Fresenius Medical Care AG & Co. (Germany), Nikkiso, Co. Ltd. (Japan), Terumo BCT, Inc. (United States), Nigale Biomedical Inc (China), B. Braun Melsungen AG (Germany), Kidde-Fenwal, Inc.(United States), Kawasumi Laboratories Inc. (Japan), Asahi Kasei Medical Co., Ltd. (Japan) and Scinomed Ltd., (United Kingdom) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Cerus Corporation (United States) and Fresenius Medical Care (Germany).
Research Analyst at AMA predicts that United States and Japanese Players will contribute to the maximum growth of Global Plasmapheresis Machines market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Plasmapheresis Machines market by Type, Application and Region.
On the basis of geography, the market of Plasmapheresis Machines has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Growing Prevalence of Chronic Diseases such as Cancer
- Advancement in Healthcare Infrastructure and Facilities
- Rising Demand for Plasma by Bio-pharmaceutical Companies Globally
- Growing Prevalence of Blood Disorders and Nervous System Conditions
- Increasing Number of Critically ill with infections and other problems such as Wilsonís disease and thrombotic thrombocytopenic purpura Patients
Market Leaders and their expansionary development strategies
In Feb 2019,Fresenius Medical Care, has successfully completed the acquisition of NxStage Medical, Inc. following approval by antitrust authorities in the United States. The acquisition will enable Fresenius Medical Care to leverage its manufacturing, supply chain and marketing competencies across the dialysis products, services and Care Coordination businesses in a less labor- and capital-intensive care setting.
On Sept 2019, Asahi Kasei Medical has completed the construction of a new plant for the spinning of cellulose hollow-fiber membranes for Planova virus removal filters in Nobeoka, Miyazaki, Japan. Virus removal filters are used to enhance safety in the production process for biotherapeutic products such as biopharmaceuticals and plasma derivatives.
Key Target AudiencePlasmapheresis Machines Manufacturer, Plasmapheresis Machines Suppliers/Distributors, Raw Material Suppliers, Healthcare Industry, Biopharmaceutical companies, Research and Development Organisation and Potential Investors
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase